Driving reinvestment in R&D for antibiotics and advocating their responsible use

Developing Antibiotic Valuation Models

There are stakeholder engagement opportunities for individuals and institutions, both public and private, which are involved in public health, research, health care, pharmaceuticals, economics, and mathematics.

Stakeholder input is required for:

– quantifying the value of new antibiotics from the perspectives of patients, physicians, payers and society as a whole. – COMPLETED

For more information on the team responsible for these activities, see Work Package 1C: Antibiotic valuation


Back to Antimicrobial Use and Stewardship

Back to Stakeholder Engagement